500 related articles for article (PubMed ID: 19767238)
1. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
[TBL] [Abstract][Full Text] [Related]
2. Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma.
Grass S; Iida S; Wikowicz A; Preuss KD; Inagaki A; Shimizu K; Ziepert M; Ueda R; Pfreundschuh M
Cancer Sci; 2011 Mar; 102(3):565-8. PubMed ID: 21205072
[TBL] [Abstract][Full Text] [Related]
3. Paraproteins of familial MGUS/multiple myeloma target family-typical antigens: hyperphosphorylation of autoantigens is a consistent finding in familial and sporadic MGUS/MM.
Grass S; Preuss KD; Thome S; Weisenburger DD; Witt V; Lynch J; Zettl F; Trümper L; Fadle N; Regitz E; Lynch H; Pfreundschuh M
Blood; 2011 Jul; 118(3):635-7. PubMed ID: 21586751
[TBL] [Abstract][Full Text] [Related]
4. Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MM.
Zwick C; Held G; Auth M; Bernal-Mizrachi L; Roback JD; Sunay S; Iida S; Kuroda Y; Sakai A; Ziepert M; Ueda R; Pfreundschuh M; Preuss KD
Int J Cancer; 2014 Aug; 135(4):934-8. PubMed ID: 24443359
[TBL] [Abstract][Full Text] [Related]
5. A frequent target of paraproteins in the sera of patients with multiple myeloma and MGUS.
Preuss KD; Pfreundschuh M; Ahlgrimm M; Fadle N; Regitz E; Murawski N; Grass S
Int J Cancer; 2009 Aug; 125(3):656-61. PubMed ID: 19405124
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of protein-phosphatase 2A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS/MM is due to an exchange of its regulatory subunits.
Preuss KD; Fadle N; Regitz E; Held G; Pfreundschuh M
Int J Cancer; 2014 Nov; 135(9):2046-53. PubMed ID: 24676687
[TBL] [Abstract][Full Text] [Related]
7. CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemia.
Neumann F; Pfreundschuh M; Preuss KD; Schormann C; Zwick C; Murawski N; Kubuschok B
Int J Cancer; 2015 Sep; 137(5):1076-84. PubMed ID: 25677163
[TBL] [Abstract][Full Text] [Related]
8. Autosomal-dominant inheritance of hyperphosphorylated paratarg-7.
Grass S; Preuss KD; Pfreundschuh M
Lancet Oncol; 2010 Jan; 11(1):12. PubMed ID: 20129126
[No Abstract] [Full Text] [Related]
9. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Grass S; Preuss KD; Wikowicz A; Terpos E; Ziepert M; Nikolaus D; Yang Y; Fadle N; Regitz E; Dimopoulos MA; Treon SP; Hunter ZR; Pfreundschuh M
Blood; 2011 Mar; 117(10):2918-23. PubMed ID: 21220746
[TBL] [Abstract][Full Text] [Related]
10. MGUS, multiple myeloma, and paratarg-7.
Lynch HT; Thomé S
Lancet Oncol; 2009 Oct; 10(10):931-2. PubMed ID: 19796746
[No Abstract] [Full Text] [Related]
11. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
[TBL] [Abstract][Full Text] [Related]
12. Familial occurrence of multiple myeloma and monoclonal gammopathy of undetermined significance in 5 siblings.
Bizzaro N; Pasini P
Haematologica; 1990; 75(1):58-63. PubMed ID: 2110928
[TBL] [Abstract][Full Text] [Related]
13. Familial monoclonal gammopathy: hyper-responsive B cells in unaffected family members.
Steingrímsdóttir H; Einarsdóttir HK; Haraldsdóttir V; Ogmundsdóttir HM
Eur J Haematol; 2011 May; 86(5):396-404. PubMed ID: 21342269
[TBL] [Abstract][Full Text] [Related]
14. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
[TBL] [Abstract][Full Text] [Related]
15. Pathway-based network analysis of myeloma tumors: monoclonal gammopathy of unknown significance, smoldering multiple myeloma, and multiple myeloma.
Dong L; Chen CY; Ning B; Xu DL; Gao JH; Wang LL; Yan SY; Cheng S
Genet Mol Res; 2015 Aug; 14(3):9571-84. PubMed ID: 26345890
[TBL] [Abstract][Full Text] [Related]
16. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
Golombick T; Diamond TH; Manoharan A; Ramakrishna R
Integr Cancer Ther; 2016 Jun; 15(2):183-9. PubMed ID: 27154182
[TBL] [Abstract][Full Text] [Related]
17. Incidence and evolution of monoclonal gammopathy of undetermined significance (MGUS) in Greece.
Anagnostopoulos A; Evangelopoulou A; Sotou D; Gika D; Mitsibounas D; Dimopoulos MA
Ann Hematol; 2002 Jul; 81(7):357-61. PubMed ID: 12185503
[TBL] [Abstract][Full Text] [Related]
18. Inheritance in MGUS and MM.
Pfreundschuh M
Oncotarget; 2015 Oct; 6(32):32287-8. PubMed ID: 26436702
[No Abstract] [Full Text] [Related]
19. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
